Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Zdenka Vanourkova"'
Autor:
Věra Čertíková Chábová, Petr Kujal, Zdeňka Vaňourková, Petra Škaroupková, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Vladimír Tesař, Bruce Hammock, John Imig, Hana Maxová, Luděk Červenka, Ivana Vaněčková
Publikováno v:
Kidney & Blood Pressure Research, Vol 44, Iss 6, Pp 1493-1505 (2019)
Introduction: Previous studies in Ren-2 transgenic hypertensive rats (TGR) after 5/6 renal ablation (5/6 NX) have shown that besides pharmacological blockade of the renin-angiotensin system (RAS) also increasing kidney tissue epoxyeicosatrienoic acid
Externí odkaz:
https://doaj.org/article/e825f8319c354c929117bd918f0dbf1d
Autor:
Ivana Vaněčková, Silvie Hojná, Zdenka Vernerová, Michaela Kadlecová, Hana Rauchová, Elzbieta Kompanowska-Jezierska, Zdeňka Vaňourková, Luděk Červenka, Josef Zicha
Publikováno v:
Frontiers in Physiology, Vol 10 (2019)
ObjectiveOur previous study in heterozygous Ren-2 transgenic rats (TGR) demonstrated that long-term treatment with endothelin receptor A (ETA) blocker atrasentan added to the renin-angiotensin system (RAS) blockade had renoprotective effects in a mod
Externí odkaz:
https://doaj.org/article/8daa08cb54f64a98ac0962f6e60ea410
Autor:
Jaroslav Hrdlička, Jan Neckář, František Papoušek, Zuzana Husková, Soňa Kikerlová, Zdenka Vaňourková, Zdenka Vernerová, Firat Akat, Jana Vašinová, Bruce D. Hammock, Sung Hee Hwang, John D. Imig, John R. Falck, Luděk Červenka, František Kolář
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Epoxyeicosatrienoic acids (EETs) and their analogs have been identified as potent antihypertensive compounds with cardio- and renoprotective actions. Here, we examined the effect of EET-A, an orally active EET analog, and c-AUCB, an inhibitor of the
Externí odkaz:
https://doaj.org/article/c98a38c7fda04e4a81194d59e2fbbc8c
Autor:
Vojtech Kratky, Zdenka Vanourkova, Matus Sykora, Barbara Szeiffova Bacova, Zdenka Hruskova, Sona Kikerlova, Zuzana Huskova, Libor Kopkan
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract To provide novel insights into the pathogenesis of heart failure-induced renal dysfunction, we compared the effects of ACE inhibitor (ACEi) and AT1 receptor blocker (ARB) on systemic and kidney hemodynamics during heart failure in normotensi
Externí odkaz:
https://doaj.org/article/268e001c1c7147fca832132a45aab7dd
Autor:
Petr Kala, Olga Gawrys, Matus Miklovic, Zdenka Vanourkova, Petra Skaroupkova, Sarka Jichova, Janusz Sadowski, Elzbieta Kompanowska Jezierska, Agnieszka Walkowska, Josef Veselka, Milos Taborsky, Hana Maxova, Ivana Vaneckova, Ludek Cervenka
Publikováno v:
Journal of Hypertension. 41:e453-e454
Autor:
Matus Miklovic, Olga Gawrys, Peter Kala, Zuzana Honetschlagerova, Sarka Jichova, Zdenka Vanourkova, Zuzana Huskova, Sona Kikerlova, Tomas Mracek, David Sedmera, Hana Maxova, Vojtech Melenovsky
Publikováno v:
Journal of Hypertension. 41:e139-e140
Autor:
Zdenka Vanourkova, Libor Kopkan, Sona Kikerlova, Barbara Szeiffova Bacova, Vojtech Kratky, Zdenka Hruskova, Matus Sykora, Zuzana Husková
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
To provide novel insights into the pathogenesis of heart failure-induced renal dysfunction, we compared the effects of ACE inhibitor (ACEi) and AT1 receptor blocker (ARB) on systemic and kidney hemodynamics during heart failure in normotensive HanSD
Autor:
Olga Gawrys, Petra Skaroupkova, Zuzana Huskova, Zuzana Honetschlagerova, Zdenka Vanourkova, Sona Kikerlova, Vojtech Melenovsky, Ludek Cervenka
Publikováno v:
Journal of Hypertension. 41:e356
Publikováno v:
Journal of Hypertension. 41:e275
Autor:
Ludek Cervenka, Zdenka Vanourkova, Zuzana Husková, Petra Škaroupková, Petr Kala, Josef Veselka, Vojtech Melenovsky, Zuzana Honetschlägerová
Publikováno v:
Circulation. 142
Introduction: There is a need to implement a preclinical model in addition to the well established ischemic or volume-overload models that would mimic the clinical course of patients with chemotherapy-induced heart failure. Doxorubicin is an anthracy